AT355554B - Verfahren zur herstellung von neuen o-(3-amino- 2-hydroxypropyl)-amidoxim-derivaten, deren saeureadditionssalzen und deren optisch aktiven antipoden - Google Patents

Verfahren zur herstellung von neuen o-(3-amino- 2-hydroxypropyl)-amidoxim-derivaten, deren saeureadditionssalzen und deren optisch aktiven antipoden

Info

Publication number
AT355554B
AT355554B AT605477A AT605477A AT355554B AT 355554 B AT355554 B AT 355554B AT 605477 A AT605477 A AT 605477A AT 605477 A AT605477 A AT 605477A AT 355554 B AT355554 B AT 355554B
Authority
AT
Austria
Prior art keywords
hydroxypropyl
amino
acid addition
addition salts
optically active
Prior art date
Application number
AT605477A
Other languages
English (en)
Other versions
ATA605477A (de
Inventor
Kalman Dipl-Ing Chem Takacs
Literati Peter Dipl-Ing C Nagy
Ilona Dipl-Ing Chem Kiss
Antal Dipl-Ing Chem Simay
Matyas Dr Szentivanyi
Sandor Dr Virag
Katalin Farago
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Priority to AT874178A priority Critical patent/AT361457B/de
Publication of ATA605477A publication Critical patent/ATA605477A/de
Application granted granted Critical
Publication of AT355554B publication Critical patent/AT355554B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/14—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
AT605477A 1976-08-27 1977-08-22 Verfahren zur herstellung von neuen o-(3-amino- 2-hydroxypropyl)-amidoxim-derivaten, deren saeureadditionssalzen und deren optisch aktiven antipoden AT355554B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT874178A AT361457B (de) 1976-08-27 1977-08-22 Verfahren zur herstellung von neuen o-(3-amino- -2-hydroxypropyl)-amidoxim-derivaten und deren saeureadditionssalzen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU76CI1682A HU177578B (en) 1976-08-27 1976-08-27 Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives

Publications (2)

Publication Number Publication Date
ATA605477A ATA605477A (de) 1979-08-15
AT355554B true AT355554B (de) 1980-03-10

Family

ID=10994625

Family Applications (1)

Application Number Title Priority Date Filing Date
AT605477A AT355554B (de) 1976-08-27 1977-08-22 Verfahren zur herstellung von neuen o-(3-amino- 2-hydroxypropyl)-amidoxim-derivaten, deren saeureadditionssalzen und deren optisch aktiven antipoden

Country Status (23)

Country Link
JP (1) JPS5350131A (de)
AT (1) AT355554B (de)
AU (1) AU521432B2 (de)
BE (1) BE858134A (de)
CA (1) CA1077506A (de)
CH (1) CH630344A5 (de)
CS (1) CS204008B2 (de)
DD (1) DD132433A5 (de)
DE (1) DE2738589A1 (de)
DK (1) DK150196C (de)
ES (1) ES462346A1 (de)
FI (1) FI68396C (de)
FR (1) FR2362845A1 (de)
GB (1) GB1582029A (de)
GR (1) GR63623B (de)
HU (1) HU177578B (de)
IL (1) IL52804A (de)
NL (1) NL187478C (de)
NO (1) NO144793C (de)
PL (1) PL107628B1 (de)
SE (1) SE435280B (de)
SU (1) SU730296A3 (de)
YU (2) YU202377A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990004584A1 (en) * 1988-10-20 1990-05-03 Biorex Kutató Fejleszto^' Kft. Novel o-(3-amino-2-hydroxypropyl)-hydroximic acid halides and process for preparing the same

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA848428B (en) * 1983-11-03 1985-06-26 Merrell Pharma Inc Novel alkoxyimino ether derivatives of 5-acyl-2(1h)-pyridiones
US4849522A (en) * 1983-11-03 1989-07-18 Merrell Dow Pharmaceuticals Novel alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
US5212314A (en) * 1983-11-03 1993-05-18 Merrell Dow Pharmaceuticals Inc. Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
JPH01169445A (ja) * 1987-12-25 1989-07-04 Fuji Photo Film Co Ltd 焦点距離切換えカメラ
HUT54347A (en) * 1989-01-10 1991-02-28 Chinoin Gyogyszer Es Vegyeszet Improved process for producing amidoximes
HU222994B1 (hu) 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
HUT78139A (hu) * 1995-12-22 2000-11-28 BIOREX Kutató és Fejlesztő Rt. Készítmény, különösen a bőr öregedési folyamatainak mérséklésére
KR100388120B1 (ko) 1998-05-11 2003-06-18 다케다 야쿠힌 고교 가부시키가이샤 저혈당 및 저지질혈 활성을 갖는 옥시이미노알칸산 유도체
AU5296799A (en) * 1998-08-03 2000-02-28 N-Gene Kutato Kft. Pharmaceutical compositions against autoimmune diseases
RS60604A (en) 2002-01-11 2006-12-15 Biorex Kutato Es Feyleszto Rt. Carboxamidine derivatives and their use in the treatment of vascular diseases
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
KR20230128462A (ko) 2020-11-19 2023-09-05 제브라 덴마크 에이/에스 아리모클로몰 시트레이트 및 이의 중간체를 제조하기 위한 공정

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990004584A1 (en) * 1988-10-20 1990-05-03 Biorex Kutató Fejleszto^' Kft. Novel o-(3-amino-2-hydroxypropyl)-hydroximic acid halides and process for preparing the same

Also Published As

Publication number Publication date
NO144793B (no) 1981-08-03
SE7709482L (sv) 1978-02-28
NL7709276A (nl) 1978-03-01
JPS6216942B2 (de) 1987-04-15
DK150196B (da) 1987-01-05
IL52804A (en) 1981-06-29
CS204008B2 (en) 1981-03-31
FI68396C (fi) 1985-09-10
AU521432B2 (en) 1982-04-01
YU237782A (en) 1983-12-31
FI772551A (fi) 1978-02-28
GB1582029A (en) 1980-12-31
SE435280B (sv) 1984-09-17
NL187478C (nl) 1991-10-16
ATA605477A (de) 1979-08-15
JPS5350131A (en) 1978-05-08
IL52804A0 (en) 1977-10-31
DK379777A (da) 1978-02-28
SU730296A3 (ru) 1980-04-25
FR2362845A1 (fr) 1978-03-24
HU177578B (en) 1981-11-28
DD132433A5 (de) 1978-09-27
NO144793C (no) 1981-11-11
DK150196C (da) 1987-07-06
NO772958L (no) 1978-02-28
YU202377A (en) 1983-12-31
CH630344A5 (en) 1982-06-15
CA1077506A (en) 1980-05-13
PL107628B1 (pl) 1980-02-29
ES462346A1 (es) 1978-06-16
FR2362845B1 (de) 1981-01-09
AU2825477A (en) 1979-03-01
BE858134A (fr) 1977-12-16
DE2738589A1 (de) 1978-03-02
FI68396B (fi) 1985-05-31
GR63623B (en) 1979-11-27

Similar Documents

Publication Publication Date Title
AT363465B (de) Verfahren zur herstellung von neuen 5-aroyl-1,2 -dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1-carbonsaeureestern und -salzen
AT340895B (de) Verfahren zur herstellung von neuen p-trifluormethylacylophenon-o- (2-aminoathyl) -oximathern und deren saureadditionssalzen
ATA889476A (de) Verfahren zur herstellung von neuen 1-aryl-2-(1 -imidazolyl)-akylsulfiden, von deren saeure- additionssalzen und optisch aktiven ver- bindungen
AT355554B (de) Verfahren zur herstellung von neuen o-(3-amino- 2-hydroxypropyl)-amidoxim-derivaten, deren saeureadditionssalzen und deren optisch aktiven antipoden
AT359064B (de) Verfahren zur herstellung von neuen 1h- -pyrazolo (3,4-b)-pyridinen und deren saeure- additionssalzen
AT347463B (de) Verfahren zur herstellung von neuen 1,1,1- triarylalkylaminen und deren saeureadditions- salzen
AT351547B (de) Verfahren zur herstellung von neuen thieno- (1,5)-benzodiazepinen und deren saeure- additionssalzen
AT355018B (de) Verfahren zur herstellung von neuen 1,2- benzisothiazolinonen und von deren salzen
AT361902B (de) Verfahren zur herstellung von neuen amino- saeurederivaten sowie deren salzen und optisch aktiven antipoden
ATA302677A (de) Verfahren zur herstellung von neuen 1,3-dihydro- heteroarylspiro/isobenzofuran)en und von deren optischen antipoden und pharmazeutisch vertraeglichen saeureadditionssalzen
AT346303B (de) Verfahren zur herstellung von neuen 7- aminobenzocycloheptenen und deren saeure- additionssalzen
ATA112277A (de) Verfahren zur herstellung von neuen 2,9-dioxa- tricyclo (4,3,1,03,7) decanen und deren salzen
AT364842B (de) Verfahren zur herstellung von neuen octahydroindolo(2,3-a)chinolizinen, deren saeureadditionssalzen und optischen antipoden
ATA328376A (de) Verfahren zur herstellung von neuen 3-aminomethyl-2-phenylbicyclo(2,2,2)octanen und deren saureadditionssalzen
AT359474B (de) Verfahren zur herstellung von neuen 5-phenoxy- 6,7,8,9-tetrahydro-cyclohepten-7-aminen und von deren saeureadditionssalzen
AT340896B (de) Verfahren zur herstellung von neuen p-halogen-acylophenon- o - (2-aminoathyl)-oximathern und deren saureadditionssalzen
AT349447B (de) Verfahren zur herstellung von neuen glycerin- 1,2-bis-(aminoalkylaethern) und deren saeure- additionssalzen
AT342565B (de) Verfahren zur herstellung von neuen 3,4-dichlorphenon-o-(2-aminoathyl)-oximathern und deren saureadditionssalzen
AT351509B (de) Verfahren zur herstellung von neuen 3-phenoxy-2 -hydroxy-1-phenoxy- oder -1-phenylthioalkyl- amino-propanen und von deren saeureadditions- salzen
AT340897B (de) Verfahren zur herstellung von neuen p-methylthioacylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen
AT351506B (de) Verfahren zur herstellung von neuen, schwefel- enthaltenden aliphatischen n-(2-aminobenzyl)- aminocarbonsaeuren und deren salzen
AT340894B (de) Verfahren zur herstellung von neuen p-nitro-acylophenon-o- (2-aminoathyl) -oximather und deren saureadditionssalzen
AT342021B (de) Verfahren zur herstellung von neuen p-methylsulfinyl-acylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen
AT361457B (de) Verfahren zur herstellung von neuen o-(3-amino- -2-hydroxypropyl)-amidoxim-derivaten und deren saeureadditionssalzen
AT348979B (de) Verfahren zur herstellung von neuen 7-aminomethylbenzocycloheptenen und deren saeureadditonssalzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee